Company Novartis India Limited

NOVARTIND

INE234A01025

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Delayed Bombay S.E. Other stock markets 02:10:15 2024-04-25 am EDT			5-day change	1st Jan Change
1,035 ^INR	+0.86%		+0.46%	+33.85%

Apr. 01	Novartis India Limited Announces Resignation of Nikhil Malpani as Company Secretary and Compliance Officer, Effective from April 30, 2024	CI
Mar. 22	Novartis Eyes Sale of Listed Unit in India	CI

Novartis India Limited is an India-based company that is engaged in the business of trading of pharmaceuticals. The Company's portfolio of medicines addresses various therapeutic needs, such as cardiovascular, eye care, immunology, metabolic, neuroscience, oncology, respiratory and organ transplant, to meet the medical needs of patients in India. In the bone and pain therapeutic area its brand is Voveran. In the transplantation immunology therapeutic area, the Company's brands include Simulect, Certican, Sandimmun, Neoral and Myfortic. In the neurosciences therapeutic area, its brands include Tegrital and Exelon.

Number of employees: 67

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	3,999	100.0 %	3,787	100.0 %	-5.28%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	3,999	100.0 %	3,787	100.0 %	-5.28%

Managers	Title	Age	Since
Shilpa Joshi DFI	Director of Finance/CFO	-	22-04-30
Bhavna Gupta AUD	Comptroller/Controller/Auditor	-	-

Members of the board	Title	Age	Since
Sanker Parameswaran BRD	Director/Board Member	64	20-06-21
Christopher Snook CHM	Chairman	-	08-07-31
Sandra Martyres BRD	Director/Board Member	71	16-04-18
Shilpa Joshi DFI	Director of Finance/CFO	-	22-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,690,797	6,708,646 ( 27.17 %)	0	27.17 %

Name	Equities	%	Valuation
NOVARTIS AG 70.68 %	17,450,680	70.68 %	215 M ₹
ATUL LTD 1.517 %	374,627	1.517 %	5 M ₹
Government of India 0.5823 %	143,767	0.5823 %	2 M ₹
Principal Asset Management Pvt Ltd. 0.0891 %	22,000	0.0891 %	271 312 ₹
Sundaram Asset Management Co. Ltd. 0.0567 %	13,999	0.0567 %	172 641 ₹
Dimensional Fund Advisors Ltd. 0.0215 %	5,306	0.0215 %	65 436 ₹
DFA Australia Ltd. 0.000680 %	168	0.000680 %	2 072 ₹
Motilal Oswal Asset Management Co. Ltd. 0.000377 %	93	0.000377 %	1 147 ₹

Novartis India Ltd.

Inspire-BKC, Part of 601 & 701 Bandra Kurla Complex

400051, Mumbai

http://www.novartis.in

address Novartis India Limited(NOVARTIND)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
NOVARTIS INDIA LIMITED	+33.85%	304M
ELI LILLY AND COMPANY	+25.61%	660B
NOVO NORDISK A/S	+25.87%	562B
JOHNSON & JOHNSON	-5.24%	358B
MERCK & CO., INC.	+16.49%	322B
ABBVIE INC.	+8.28%	297B
ASTRAZENECA PLC	+7.09%	219B
ROCHE HOLDING AG	-9.12%	196B
NOVARTIS AG	+5.01%	199B
PFIZER, INC.	-8.75%	149B

Other Pharmaceuticals